# LizarBio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lizarbio-therapeutics

- Industry: Biotechnology
- Headquarters: Sao Paulo, Brazil
- Website: www.lizar.bio
- Latest round: Seed (Mar 7, 2022)
- Investors on record: 1

## About

LizarBio Therapeutics is a biotechnology firm specializing in innovative biologically-based products designed to enhance agricultural efficiency and sustainability through the use of biofertilizers and biopesticides.Founded in 2013 and headquartered in Sao Paulo, Brazil, LizarBio Therapeutics focuses on developing biologically-based agricultural solutions. The company has successfully completed one funding deal as of March 7, 2022. The founder's detailed background is not available, but the firm operates independently with no noted changes to its business strategy.Lizar Bio specializes in innovative solutions within the biotechnology sector, focusing on biologically-based products designed to enhance agricultural efficiency and sustainability. Their core offerings include advanced biofertilizers and biopesticides that leverage natural microorganisms to promote plant growth, improve soil health, and reduce dependency on chemical fertilizers and pesticides. These products are engineered to address specific agricultural challenges, such as soil degradation and pest resistance, and are particularly beneficial for organic farming practices. The company's solutions cater primarily to farmers and agricultural distributors in North America, Europe, and parts of Latin America, aiming to serve a client base that values sustainable and environmentally-friendly agricultural practices.Lizar Bio generates revenue through a combination of direct sales and strategic partnerships with agricultural distributors. Typically, transactions involve a B2B model where the company sells its biofertilizers and biopesticides to wholesalers and retailers, who then offer these products to end-users such as farmers and agricultural enterprises. The revenue structure may include tiered pricing based on volume purchases, with flagship products being promoted through bundled offerings that incentivize larger orders. Specific pricing details for individual products or service packages are structured to reflect the value provided in enhancing agricultural productivity and sustainability, thereby establishing a clear value proposition for clients within the agricultural sector.Following their most recent funding round in March 2022, where LizarBio Therapeutics raised an undisclosed amount of Seed funding from new investor SOSV, the company plans to expand its product line further. They are actively designing new biofertilizer and biopesticide products targeted for launch within the next 18 months. Additionally, LizarBio aims to enter new markets in Asia Pacific and Africa by 2024, leveraging the recent funding to support these initiatives.

## Funding rounds

- Seed, Mar 7, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed